Skip to main content
Clinical Trials/NCT04689932
NCT04689932CompletedPhase 4

Triferic AVNU Infusion Via Freedom Pump During Hemodialysis

Rockwell Medical Technologies, Inc.1 site in 1 country12 target enrollmentStarted: April 19, 2021Last updated:
Conditions
Interventions
Drugs

Trial Snapshot

Phase
Phase 4
Status
Completed
Enrollment
12
Locations
1
Primary Endpoint
Time for Complete Infusion of 4.5 mL Triferic AVNU Pre-Dialyzer

Study Overview

Brief Summary

The main purpose of this study is to evaluate the delivery of Triferic AVNU intravenously using the Freedom Pump-20 during hemodialysis into the pre-dialyzer and post-dialyzer blood lines.

Detailed Description

This is a single center, multi dose, open label study assessing the delivery of Triferic AVNU administered intravenously to adult patients (> or equal to 18 years of age) using the Freedom Pump-20 during hemodialysis into the pre-dialyzer and post-dialyzer blood lines.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Sequential
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • Participant must be 18 years of age inclusive, at the time of signing the informed consent.
  • Receiving chronic hemodialysis for 3-4 hours each session 3x/week.
  • Medically stable according to the investigator opinion
  • Capable of giving signed informed consent which includes compliance with the requirements and restrictions listed in the informed consent form (ICF) and in this protocol.

Exclusion Criteria

  • Hemodynamically unstable during hemodialysis
  • Evidence of active bleeding from the GI tract.

Arms & Interventions

Pre- Dialyzer Infusion and Post- Dialyzer Infusion

Experimental

On study day 1, day 3 and day 5, patients will receive 6.75 mg Fe/4.5 mL Triferic AVNU intravenously using the Freedom Pump-20 during hemodialysis into the pre-dialyzer blood line. On study day 2, day 4 and day 6, patients will receive the 6.75 mg Fe/4.5 mL Triferic AVNU intravenously using the Freedom Pump-20 during hemodialysis into the post dialysis blood line.

Intervention: Triferic AVNU (Drug)

Outcomes

Primary Outcomes

Time for Complete Infusion of 4.5 mL Triferic AVNU Pre-Dialyzer

Time Frame: On Days 1, 3, and 5, up to 3 hours

The syringe pump and flow restrictor tubing has a nominal flow rate of 2 mL/hour. When the tubing is connected to the pre-dialyzer or post dialyzer blood circuit the administration time will vary due to the pressure in the dialyzer blood lines. For a 4.5 mL volume the target administration rate is 2.25 hours. The Product labeling for Triferic AVNU advises the dose (4.5 mL) to be administered over 3 to 4 hours.

Time for Complete Infusion of 4.5 mL Triferic AVNU Post-Dialyzer

Time Frame: On Days 2, 4, and 6, up to 3 hours

The syringe pump and flow restrictor tubing has a nominal flow rate of 2 mL/hour. When the tubing is connected to the pre-dialyzer or post dialyzer blood circuit the administration time will vary due to the pressure in the dialyzer blood lines. For a 4.5 mL volume the target administration rate is 2.25 hours. The Product labeling for Triferic AVNU advises the dose (4.5 mL) to be administered over 3 to 4 hours.

Secondary Outcomes

  • Mean TSAT Max Post-Dialyzer(up to 3 hours)
  • Mean TSAT Max Pre-Dialyzer(up to 3 hours)

Investigators

Sponsor Class
Industry
Responsible Party
Sponsor

Study Sites (1)

Loading locations...

Similar Trials

Triferic AVNU Infusion Via Freedom Pump... | Clinical Trial